- Home
- KURA vs PRTH Comparison
KURA vs PRTH Comparison
Compare KURA & PRTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- PRTH
- Stock Information
- Founded
- KURA 2014
- PRTH 2005
- Country
- KURA United States
- PRTH United States
- Employees
- KURA N/A
- PRTH N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- PRTH EDP Services
- Sector
- KURA Health Care
- PRTH Technology
- Exchange
- KURA Nasdaq
- PRTH Nasdaq
- Market Cap
- KURA 561.9M
- PRTH 550.3M
- IPO Year
- KURA N/A
- PRTH N/A
- Fundamental
- Price
- KURA $7.34
- PRTH $7.62
- Analyst Decision
- KURA Strong Buy
- PRTH Strong Buy
- Analyst Count
- KURA 13
- PRTH 4
- Target Price
- KURA $24.45
- PRTH $12.25
- AVG Volume (30 Days)
- KURA 1.5M
- PRTH 513.7K
- Earning Date
- KURA 08-07-2025
- PRTH 08-07-2025
- Dividend Yield
- KURA N/A
- PRTH N/A
- EPS Growth
- KURA N/A
- PRTH N/A
- EPS
- KURA N/A
- PRTH 0.26
- Revenue
- KURA $83,279,000.00
- PRTH $918,558,000.00
- Revenue This Year
- KURA $125.04
- PRTH $12.44
- Revenue Next Year
- KURA $83.75
- PRTH $10.40
- P/E Ratio
- KURA N/A
- PRTH $28.77
- Revenue Growth
- KURA N/A
- PRTH 12.86
- 52 Week Low
- KURA $5.41
- PRTH $4.62
- 52 Week High
- KURA $21.57
- PRTH $12.47
- Technical
- Relative Strength Index (RSI)
- KURA 67.38
- PRTH 53.81
- Support Level
- KURA $5.45
- PRTH $6.97
- Resistance Level
- KURA $6.74
- PRTH $8.04
- Average True Range (ATR)
- KURA 0.38
- PRTH 0.42
- MACD
- KURA 0.10
- PRTH 0.12
- Stochastic Oscillator
- KURA 82.17
- PRTH 72.79
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About PRTH Priority Technology Holdings Inc.
Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium business enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments, and Enterprise Payments. SMB Payments segment which generates the majority of revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging Priority's proprietary software platform, distributed through ISO; the B2B Payments segment provides AP automation solutions to corporations, software partners, & industry FIs: and Enterprise Payments segment provides embedded payment & treasury solutions to enterprise customers to modernize legacy platforms & accelerate software partners' strategies to monetize payments.